There are 36 resources available
Participants clinical case discussion: Neoadjuvant treatment of HER2+PD-L1+UTUC with trastuzumab deruxtecan and pembrolizumab
Presenter: L. Edlinger, AT
Session: SESSION 2 - Bladder Cancer – Part II
Resources:
Slides
Webcast
Participants clinical case discussion: Beyond the Norm: Tackling an Atypical Case of Metastatic Urothelial Cancer
Presenter: M. Semmler, DE
Session: SESSION 2 - Bladder Cancer – Part II
Resources:
Slides
Webcast
Is there a role for nephrectomy in advanced disease?
Presenter: A. Bex, NL
Session: SESSION 3 - Renal Cancer – Part I
Resources:
Slides
Webcast
Is there a role for neoadjuvant treatment in RCC?
Presenter: A. Bex, NL
Session: SESSION 3 - Renal Cancer – Part I
Resources:
Slides
Webcast
Oligometastatic disease management
Presenter: G. De Velasco, ES
Session: SESSION 3 - Renal Cancer – Part I
Resources:
Slides
Webcast
Participants clinical case discussion: Kidney Cancer in patients during dialysis
Presenter: A. Semeniuk-Wojtas, PL
Session: SESSION 3 - Renal Cancer – Part I
Resources:
Slides
Webcast
Participants clinical case discussion: Precision medicine in malignant oncocytoma
Presenter: J. Esteban Villarrubia, ES
Session: SESSION 3 - Renal Cancer – Part I
Resources:
Slides
Webcast
Participants clinical case discussion: ccRCC – When your patient is a surgeon
Presenter: B. Van Holder, BE
Session: SESSION 3 - Renal Cancer – Part I
Resources:
Slides
Webcast
Participants clinical case discussion: Non-clear cell renal cancer: an heterogeneous disease - What is the best treatment option?
Presenter: M. Falcão, PT
Session: SESSION 3 - Renal Cancer – Part I
Resources:
Slides
Webcast
Summary of adjuvant therapies for RCC
Presenter: C. Suarez, ES
Session: SESSION 4 - Debate around adjuvant therapy for RCC
Resources:
Slides
Webcast